Christoph Reiter
- Molecular Biology
- Organic Chemistry top 5%
- Public Health, Environmental and Occupational Health top 10%
- Pharmacology top 5%
- Infectious Diseases top 10%
- Co-authors
- Svetlana B. TsogoevaTony FröhlichThomas EfferthAysun ÇapcıManfred MarschallBarbara KappesOliver FriedrichRichard M. Weinshilboum
- Topics
- Bioactive Compounds and Antitumor Agents (4 papers)Nigella sativa pharmacological applications (4 papers)HIV/AIDS drug development and treatment (4 papers)
- Partner nations
- GermanyUnited StatesJordan
In The Last Decade
Christoph Reiter
16 papers receiving 973 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 380
- Organic Chemistry 357
- Public Health, Environmental and Occupational Health 240
- Pharmacology 144
- Infectious Diseases 141
Countries citing papers authored by Christoph Reiter
This map shows the geographic impact of Christoph Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Reiter more than expected).
Fields of papers citing papers by Christoph Reiter
This network shows the impact of papers produced by Christoph Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Reiter. The network helps show where Christoph Reiter may publish in the future.
Co-authorship network of co-authors of Christoph Reiter
This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Reiter. A scholar is included among the top collaborators of Christoph Reiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Reiter. Christoph Reiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 41 | |
| 3 | 74 | |
| 4 | 71 | |
| 5 | 144 | |
| 6 | 70 | |
| 7 | 97 | |
| 8 | 103 | |
| 9 | 48 | |
| 10 | 77 | |
| 11 | 18 | |
| 12 | 43 | |
| 13 | Erstellung von Emissionskennfeldern | 1 |
| 14 | 106 | |
| 15 | 15 | |
| 16 | 55 |
About Christoph Reiter
Christoph Reiter is a scholar working on Toxicology, Complementary and alternative medicine and Pharmacology, having authored 16 papers that have together received 989 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (4 papers), Nigella sativa pharmacological applications (4 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Toxicology (102 citations), Pharmacology (144 citations) and Organic Chemistry (357 citations). Christoph Reiter has collaborated with scholars based in Germany, United States and Jordan. Frequent co-authors include Svetlana B. Tsogoeva, Tony Fröhlich, Thomas Efferth, Aysun Çapcı, Manfred Marschall, Barbara Kappes, Oliver Friedrich, Richard M. Weinshilboum, Maria Leidenberger and Corina Hutterer. Their work appears in journals such as Journal of Medicinal Chemistry, Molecules and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.